Journal of Addiction Medicine

Article	Citations
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	101
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases	71
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	68
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	56
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	55
Implantable Cardioverter Defibrillator Placement to Permit Ongoing Methadone Treatment Despite QT Prolongation and Torsades de Pointes: A Case Report	42
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	41
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	41
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	40
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	38
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	36
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	34
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	32
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	30
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	29
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program	27
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	25
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study	25
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	25
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds	24
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	23
Gains in Employment Status Are Associated With Lower Methamphetamine Use Frequency at Outpatient Specialty Treatment Discharge	22
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	21
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	21
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	21

Identifying Areas to Improve Care and Support Parent-Child Relationships From the Perspective of Pregnant and Parenting People in Recovery	20
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review	19
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique	19
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	18
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	17
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	17
Dosing and Safety of Methadone Initiation in the Setting of Fentanyl: A Systematic Review	17
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	17
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	17
Fentanyl Test Strips for Harm Reduction: A Scoping Review	16
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	16
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	16
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	16
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	16
Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial	15
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	14
Use of Cannabinoids by People Who Consume Kratom in the United States	13
Rating the Quality and Consistency of Local Opioid Settlement Expenditure Data	13
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	13
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	13
Fertility Beliefs and Menstrual Experiences Among Women Entering Opioid Use Disorder Treatment	13
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	13
Current State of Perioperative Buprenorphine Management—A National Provider Survey	12
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	12
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	12
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	12
Trends in Buprenorphine and Methadone Initiation for Opioid Use Disorder Among Patients Using Fentanyl: A Mixed-methods Analysis From an Inpatient Addiction Consult Service	12
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	12
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	12
Online Narcotics Anonymous: An Option for Addressing Methamphetamine Use Disorder	11
A Hospital-based Managed Alcohol Program in a Canadian Setting	11
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	11
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	11
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	11
Climate Change and the Opioid Epidemic	11
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	11
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	11
The Difficulties in Finding the Relevant Associations Between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	10
Xylazine Test Strip Use Among People Who Use Drugs in New York State	10
Aripiprazole Is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	10
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	10
Too Many Pills, Too Little Attention: Emphasizing Psychotropic Polypharmacy in the Overdose Conversation	10
Letter in Reply	10
Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women	10
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	10
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	10
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	10
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	10
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	10

Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	10
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	10
N-acetylcysteine Efficacy on Cocaine Base Paste Use Disorder: A Randomized Double-blind Placebo-controlled Clinical Trial	9
Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use Disorder	9
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	9
A Scoping Review of Youth Overdose Prevention Interventions	9
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	9
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	9
Direct Induction of Buprenorphine Extended-Release: A Case Report	9
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	9
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine	9
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	9
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	9
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	9
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	9
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	9
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	9
Addiction Services for Veterans: Opportunities in Acute Care	9
Methadone and Torsades de Pointes: A Case Series	9
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	9
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	8
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	8
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	8
Validating the Waterpipe Addiction, Craving, and Anticipation Scale: An Exploratory Factor Analysis	8
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	8
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	8
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	8
Prevalence of Kratom Use Disorder Among Kratom Consumers	8
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	8
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	8
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine Treatment	8
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	8
Factors Associated With Telehealth Buprenorphine Initiation	8
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	8
Identifying Factors Associated With Intentional and Unintentional Fentanyl Use Among People Who Use Drugs in New York City	8
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	8
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	8
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	8
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	7
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	7
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	7
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	7
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	7
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	7
Health Care Service Presence, Social Vulnerability, and Opioid Overdose Rate Acceleration: A United States, County-level Analysis, 2020–2022	7
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	7
Opioid Use Disorder Screening Practices in US Jails	7
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	7
Community-based Care Coordination and Treatment Retention in Opioid Use Disorder	7
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	7
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	7
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	7
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	7
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	7
Response to the Federation of State Physician Health Program's Commentary	7
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	7
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	7
Response to Martins et al.	7
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	6
A Critical Appraisal on the Alleged Carcinogenic Potential of Sublingual Buprenorphine	6
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	6
Emergency Department Presentations Related to the Abuse of Illicit and Prescription Opioids Through a European Sentinel-centres–Based Registry	6
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	6
Ibogaine for Opioid Use Disorder: An Unrecognized Risk	6
Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder	6
A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Challenges of Drug Testing in Addiction Treatment	6
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	6
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	6
Naloxone Prescribing and Naloxone Administration in Response to Overdose Events Among Women With Opioid Use Disorder During Pregnancy and Postpartum Period – MAT-LINK, Seven Clinical Sites, 2014–2021	6
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	6
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	6
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
Response to Correspondence on “Precipitated Withdrawal Following Emergency Department-initiated Buprenorphine: A Retrospective Study	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	6
Response to: “Clinician Perspectives on Barriers and Facilitators to Providing Medications for Opioid Use Disorder for Adolescents”	6

Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	5
Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles	5
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	5
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	5
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	5
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis	5
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	5
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	5
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	5
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	5
Does Labetalol Trigger False Positive Drug Testing Results?	5
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	5
Opioid Agonist Therapy for Fentanyl-Related Opioid Use Disorder: A Systematic Review	5
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	5
The First 100 Days: The Trump Administration and Changes to Addiction Policy	5
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	5
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	5
Prevalence and Correlates of Past-year Kratom Use Among US Adults: Findings From the 2021–2023 National Survey on Drug Use and Health	5
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	5
Benzodiazepine Tapering: Evidence Limitations and Research Recommendations	5
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	5
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	5
Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series	5
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
Kava-potentiated Withdrawal in Persons Using Multiple Substances: A Case Series of Kava and Kratom Co-ingestion	4
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	4
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	4
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	4
From Management to Maintenance: A Pilot Ambulatory Gabapentin Bridge Protocol for Treatment of Low-risk Alcohol Withdrawal Syndrome	4
Response to: Buprenorphine Initiation, Patient Autonomy, and Informed Consent	4
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	4
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents	4
Dutasteride as a Treatment to Support Reduced Drinking: A Randomized Placebo-Controlled Trial	4
Precipitated Withdrawal following Emergency Department-initiated Buprenorphine: A Retrospective Study	4
Facilitating Integrated Perinatal Care for Families Affected by Substance Use	4
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	4
Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series	4
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder	4
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria	4
2024 ASAM Annual Conference Poster Abstracts	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	4
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	4
Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students	4
An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention	4
A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment	4
Impact of X-Waiver Elimination on Post–Hospital Discharge Buprenorphine Prescribing: An Interrupted Time Series Analysis	4
National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders	4
“The Sky Didn’t Fall”: Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion	4
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients	4
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	4
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	4
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	4
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	4
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	4
Racial Disparities in Urine Toxicology Screening Among Pregnant People Admitted to Labor and Delivery	4
Privacy and Digital Health: Causes for Concern and a Way Forward	4
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	4
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	4
Global, Regional, and National Burdens Attributable to Drug Use Across 204 Countries and Territories Between 1990 and 2021: The Global Burden of Disease Study 2021	4
Association Between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial	4
Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study	4
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals With an Addiction Consult Service	4
Description of Physician Champion Efforts to Expand Buprenorphine Treatment in Primary Care and Explore a Quality Implementation Measure of Success: Buprenorphine as a Percentage of All Opioids Prescr	4
Impact of Cocaine Use Disorder History on Receipt of Guideline-indicated Medications and Therapies Following ST-elevated Myocardial Infarction	4
County-Level Uptake of Take-Home Methadone and Adverse Events Among Commercially Insured Individuals	4